Healthcare Sales & Marketing Network News: kidney failure

Searching News Database: kidney failure

HSMN NewsFeed - 16 Jan 2026
Sobi Receives European Commission Approval for Aspaveli(R) (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Sep 2025
J & D Pharmaceuticals LLC Receives Orphan Drug Designation for Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Biopharmaceuticals FDA

HSMN NewsFeed - 23 May 2025
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Aug 2024
Sobi and Apellis announce positive topline results from phase 3 VALIANT study of pegcetacoplan in C3G and primary IC-MPGN
Biopharmaceuticals

HSMN NewsFeed - 29 May 2024
Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
Devices Diagnostics Cardiology FDA

HSMN NewsFeed - 19 Jan 2024
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 13 Dec 2023
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Myasthenia Gravis
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jan 2023
SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
Devices Venture Capital

HSMN NewsFeed - 13 Jul 2022
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
Devices

HSMN NewsFeed - 1 Jun 2022
CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries
Devices Distribution

HSMN NewsFeed - 20 Sep 2021
Bluegrass Vascular Announces Decision by Medicare to Assign a New Technology Ambulatory Payment Classification (APC) for the Surfacer(R) System Procedure
Devices Reimbursement

HSMN NewsFeed - 14 May 2021
FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz(R) IND for Stroke Treatment
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 13 May 2021
Healionics Raises $4.7M Equity Round to Support Commercialization of Stargraft Vascular Graft
Devices Venture Capital

HSMN NewsFeed - 16 Nov 2020
Mallinckrodt Announces Data from a Multicenter Post Hoc Analysis of Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at The Liver Meeting Digital Experience
Biopharmaceuticals

HSMN NewsFeed - 14 Sep 2020
Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 May 2020
DaVita Launches Venture Group to Accelerate Advancements in Kidney Care
Venture Capital

HSMN NewsFeed - 10 Dec 2019
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Nov 2019
Otsuka Announces Retirement of President & Chief Executive Officer William H. Carson, M.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Nov 2019
Regeneron Provides Updates on Phase 3 Libtayo(R) (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Aug 2019
Mallinckrodt Announces Positive Top-Line Results from its Pivotal Phase 3 CONFIRM Trial of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1)
Biopharmaceuticals

HSMN NewsFeed - 5 Aug 2019
Instrumentation Laboratory Presents New GEM Premier ChemSTAT(TM) Testing System With iQM(R) At American Association For Clinical Chemistry Annual Meeting
Diagnostics Product Launch

HSMN NewsFeed - 1 Jul 2019
U.S. CPT Code Granted for KidneyIntelX(TM)
Diagnostics Reimbursement

HSMN NewsFeed - 20 Jun 2019
OxThera Initiates Extension Part of a Phase 3 Study of Oxabact in Primary Hyperoxaluria
Biopharmaceuticals

HSMN NewsFeed - 7 Jun 2019
Study Published in Journal of Clinical Investigation Insight Demonstrates Ability to Predict Early Rejection in Kidney Transplant with FractalDx Portfolio Technology
Diagnostics

HSMN NewsFeed - 6 May 2019
Fresenius Medical Care North America Announces Leadership Additions Following NxStage Merger
Devices Personnel

HSMN NewsFeed - 2 May 2019
FDA Grants Breakthrough Device Designation to KidneyIntelX(TM)
Diagnostics FDA

HSMN NewsFeed - 15 Apr 2019
Data on Impact of Revised Consensus Recommendations on Time to Treatment and Serum Creatinine (SCr) at Treatment Start for Patients with Hepatorenal Syndrome Type 1 (HRS-1) Presented at the 2019 International Liver Congress(TM) (EASL)
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2019
Instrumentation Laboratory Receives US FDA Clearance For New Gem Premier Chemstat(TM) Testing System
Diagnostics FDA

HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Aug 2018
Cumberland Pharmaceuticals Appoints New Senior Executive
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jul 2018
Laminate Medical Technologies announces first forearm fistula cases in Germany
Devices

HSMN NewsFeed - 9 Jul 2018
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
Devices Mergers & Acquisitions

HSMN NewsFeed - 13 Apr 2018
Medisystems Announces US Release of MasterGuard(R) Plus
Devices Drug Delivery Product Launch

HSMN NewsFeed - 12 Apr 2018
TransMedics, Inc. Receives FDA Pre-Market Approval (PMA) for its OCS(TM) Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation
Devices Surgery FDA

HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution

HSMN NewsFeed - 26 Feb 2018
New Data Show Lilly's Trulicity(R) (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology

HSMN NewsFeed - 13 Oct 2017
Dr. Bastian Dehmel Appointed CMO of OxThera
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Biopharmaceuticals Oncology Product Launch

HSMN NewsFeed - 30 Aug 2017
Stent Tek Closes Series a Investment Round for its ePATH AVF Device, Aiming to Improve Vascular Access for Hemodialysis
Devices Venture Capital

HSMN NewsFeed - 28 Aug 2017
NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage(R) System One(TM)
Devices FDA

HSMN NewsFeed - 5 Jul 2017
Matthew Gantz Appointed CEO of OxThera
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2017
100,000th Robotic-Arm Assisted Joint Replacement Procedure Performed in the U.S. with Stryker's Mako System
Devices Orthopaedic

HSMN NewsFeed - 8 Feb 2017
FDA Approves Amgen's Parsabiv(TM) (Etelcalcetide), First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On Hemodialysis
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 3 Feb 2017
NxStage Announces Appointment of Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 11 Jan 2017
Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv(TM) (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
Biopharmaceuticals

HSMN NewsFeed - 29 Nov 2016
OxThera Raises EUR 32 Million to Complete Development of Oxabact(R) for Treatment of Primary Hyperoxaluria
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Nov 2016
First Successful Treatment of Dengue Fever and Dengue Shock Syndrome Using CytoSorb(R)
Devices

HSMN NewsFeed - 24 Oct 2016
Baxter Launches HDx Therapy Enabled by THERANOVA to Provide High Performance Hemodialysis Treatments
Devices Product Launch

HSMN NewsFeed - 8 Jul 2016
NEPHROCHECK(R) Test Predicts Acute Kidney Injury Risk In Sepsis Patients Including Those With Other Organ Failures
Diagnostics

HSMN NewsFeed - 26 May 2016
TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy
Devices Venture Capital

HSMN NewsFeed - 17 Mar 2016
Healionics Announces New CEO
Devices Personnel

HSMN NewsFeed - 5 Feb 2016
TVA Medical Receives Additional Reimbursement in Germany for the everlinQ(TM) endoAVF System
Devices Interventional Reimbursement

HSMN NewsFeed - 25 Jan 2016
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
Biopharmaceuticals Distribution Product Launch

HSMN NewsFeed - 20 Jan 2016
Orphan Medicine Designation and European Medicines Agency Public Opinion Summary Published by EMA Regarding Alferon N Injection(R) as a Treatment of Middle East Respiratory Syndrome (MERS)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Oct 2015
Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Jun 2015
Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Feb 2015
Genentech’s Phase III Study of Gazyva(R) Showed Significant Benefit in Refractory Indolent Non-Hodgkin’s Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Dec 2014
NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis
Devices FDA

HSMN NewsFeed - 22 May 2014
Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective
Devices Cardiology

HSMN NewsFeed - 16 Apr 2014
OxThera AB Receives SEK 70 Million Financing to Continue its Key Clinical Programs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 31 Dec 2013
Miraculins and Cachet Pharmaceutical Agree to 30-Day Extension on Letter of Intent to Continue Negotiation of Licensing Rights for SCOUT DS(R) Diabetes Test in China
Diagnostics Endocrinology Licensing

HSMN NewsFeed - 2 Dec 2013
Siemens Launches Artis one Angiography System for Universal Use
Devices Radiology Product Launch

HSMN NewsFeed - 5 Nov 2013
CVRx(R) & DaVita Announce Strategic Partnership
Devices

HSMN NewsFeed - 1 Nov 2013
FDA Approves Gazyva (Obinutuzumab) for People With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 30 Oct 2013
CVRx Closes $12 Million Additional Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 13 Sep 2013
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
Biopharmaceuticals Regulatory

HSMN NewsFeed - 29 Aug 2013
St. Jude Medical Receives European Approval for New Renal Denervation System That Reduces Total Ablation Time by More Than 80 Percent
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 26 Jun 2013
Freedom Meditech Announces U.S. Commercial Launch of ClearPath DS-120(TM) Device to Measure Autofluorescence in the Lens of the Eye
Devices Ophthalmology Product Launch

HSMN NewsFeed - 10 Jun 2013
TVA Medical Raises $9.5 Million to Advance Minimally Invasive Therapy for End-Stage Renal Disease
Devices Venture Capital

HSMN NewsFeed - 4 Jun 2013
St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure
Devices Cardiology Interventional

HSMN NewsFeed - 14 May 2013
St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
Devices Interventional Cardiology

HSMN NewsFeed - 30 Apr 2013
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
Devices FDA

HSMN NewsFeed - 25 Feb 2013
NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients
Devices Regulatory

HSMN NewsFeed - 21 Feb 2013
NxStage Announces CE Mark Approval for New High Flow Capabilities with System One
Devices Regulatory

HSMN NewsFeed - 21 Feb 2013
SynCardia Total Artificial Heart Patient with End-Stage Renal Failure Recovers Kidney Function after Two Months of Support
Devices Cardiology

HSMN NewsFeed - 19 Sep 2012
OxThera Raises Capital for Further Clinical Development of Oxabact(R)
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Aug 2012
Renal Denervation Technology from St. Jude Medical Demonstrates Safe, Rapid and Sustained Reduction in Blood Pressure
Devices Cardiology

HSMN NewsFeed - 14 Jun 2012
Dexcom Receives CE Mark Approval for the Dexcom G4(R) Continuous Glucose Monitoring System
Devices Monitoring Endocrinology Regulatory

HSMN NewsFeed - 7 Jun 2012
OxThera Resumes Clinical Development of Hyperoxaluria Therapy
Biopharmaceuticals

HSMN NewsFeed - 16 May 2012
Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure
Devices Cardiology

HSMN NewsFeed - 15 May 2012
St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal Denervation System for Treatment of Hypertension
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 23 Mar 2012
BYETTA(R) Approved for Use with Basal Insulin in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 15 Mar 2012
Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant Rejection
Diagnostics

HSMN NewsFeed - 29 Nov 2011
Soliris(R) (eculizumab) Granted Marketing Authorization in Europe for Treatment of Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Jul 2011
Phase III Trial of Novartis Drug Afinitor(R) Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Biopharmaceuticals

HSMN NewsFeed - 30 Jun 2011
Tengion Announces Leadership Transition
Regenerative Medicine Personnel

HSMN NewsFeed - 4 May 2011
NxStage(R) Advances Global Growth Strategy with System One Regulatory Approval and Distribution Agreement in Australia and New Zealand
Devices Distribution

HSMN NewsFeed - 19 Apr 2011
FDA Approves Rituxan Plus a Steroid for Use in Severe Forms of Vasculitis
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Apr 2011
Alexion Submits Applications for Soliris(R) (Eculizumab) as a Treatment for Patients with Atypical Hemolytic Uremic Syndrome (aHUS) in the United States and European Union
Biopharmaceuticals

HSMN NewsFeed - 8 Mar 2011
Fresenius Medical Care Acquires Hema Metrics Crit-Line(R) System Business
Devices Acquisitions

HSMN NewsFeed - 22 Feb 2011
Gore Receives CE Mark for GORE(R) PROPATEN(R) Vascular Graft for Hemodialysis Access
Devices Regulatory

HSMN NewsFeed - 20 Feb 2011
Fresenius Medical Care Receives FDA Clearance for 2008K@home(TM) Dialysis Machine
Devices FDA

HSMN NewsFeed - 24 Sep 2010
Cook Medical Files Pre-Market Approval Application for FDA Approval of A Balloon Expandable Stent for Renal Artery Disease
Devices Interventional FDA

HSMN NewsFeed - 26 Jul 2010
FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Jul 2010
Fresenius Medical Care Enters into Long-Term Distribution Agreement in Japan and Expands Dialysis Products Business in Korea
Devices Distribution

HSMN NewsFeed - 10 Jun 2010
Human Genome Sciences Announces Submission of Biologics License Application to FDA for BENLYSTA(R) (belimumab)
Biopharmaceuticals

HSMN NewsFeed - 7 Jun 2010
Human Genome Sciences Announces Submission of Marketing Authorization Application to EMA for BENLYSTA(R) (Belimumab)
Biopharmaceuticals

HSMN NewsFeed - 6 May 2010
MitraClip Safely Relieves Symptoms in Patients With No Surgical Options
Devices Interventional Cardiology

HSMN NewsFeed - 20 Apr 2010
Human Genome Sciences and GlaxoSmithKline Announce Topline 76-Week Results of Phase 3 Trial of BENLYSTA in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 31 Mar 2010
Abbott Submits Test to Aid in Identifying Patients at Risk of Developing Kidney Injury
Diagnostics FDA

HSMN NewsFeed - 16 Mar 2010
Cheetah Medical Closes $20 Million Series B Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 8 Mar 2010
NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome
Devices

HSMN NewsFeed - 2 Mar 2010
NxStage(R) and Dirinco Sign Distribution Agreement For System One(TM) in the Netherlands
Devices Distribution

HSMN NewsFeed - 3 Feb 2010
NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
Devices Distribution

HSMN NewsFeed - 1 Feb 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Dec 2009
American Diabetes Association's New Clinical Practice Recommendations Promote A1C as Diagnostic Test for Diabetes
Diagnostics Endocrinology

HSMN NewsFeed - 9 Dec 2009
Fresenius Medical Care Announces Management Board Changes
Devices Personnel

HSMN NewsFeed - 7 Dec 2009
Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Nov 2009
Diabetes Prevalence Expected to Double in Next 25 Years
Endocrinology Wound Care

HSMN NewsFeed - 2 Nov 2009
Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 20 Oct 2009
Human Genome Sciences and GlaxoSmithKline Announce Full Presentation at ACR of Positive Phase 3 Study Results for BENLYSTA in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2009
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 21 Sep 2009
Breakthrough Test Can Prevent Fatal Kidney Failure
Diagnostics

HSMN NewsFeed - 17 Sep 2009
Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line for Maintenance
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Sep 2009
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 5 Aug 2009
XDx Completes $14.4 Million Series G Financing
Diagnostics Venture Capital

HSMN NewsFeed - 20 Jul 2009
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 17 Jun 2009
NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
Devices Distribution

HSMN NewsFeed - 1 Apr 2009
Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
Biopharmaceuticals

HSMN NewsFeed - 23 Mar 2009
Dialysis is Changing: New Treatment Options Offer Patients Greater Flexibility and Control over Lifestyle
Devices

HSMN NewsFeed - 11 Mar 2009
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
Biopharmaceuticals

HSMN NewsFeed - 10 Mar 2009
Fresenius Medical Care Announces Resignation of Lawrence A. Rosen, Chief Financial Officer
Devices Personnel

HSMN NewsFeed - 9 Mar 2009
NxStage Reports Sustained Reduction in Clinical Depressive Symptoms for Daily Home Hemodialysis Patients After One Year
Devices

HSMN NewsFeed - 17 Feb 2009
GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 27 Jan 2009
SurModics and Nexeon MedSystems to Collaborate on Development of Novel Stent System for Renal Artery Disease
Devices Interventional

HSMN NewsFeed - 27 Jan 2009
Archemix Announces Continued Progress with Business Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Nov 2008
NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
Devices

HSMN NewsFeed - 22 Oct 2008
FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Sep 2008
Tengion Appoints Brian J. G. Pereira, M.D. to its Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 16 Sep 2008
Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Sep 2008
Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 6 Aug 2008
Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke in Patients with Heart Disease, Type 2 Diabetes and Chronic Kidney Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Jul 2008
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 14 Jul 2008
FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 22 Apr 2008
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Apr 2008
High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients with Chronic Kidney Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Apr 2008
Fresenius Medical Care Announces Status in Patent Case
Devices Litigation

HSMN NewsFeed - 24 Mar 2008
ConforMIS, Inc. Appoints Medical Device Veteran to Chief Operating Officer
Devices Personnel

HSMN NewsFeed - 19 Mar 2008
Cook Medical Announces the Launch and First Patient Enrollment of the REFORM Clinical Trial
Devices Interventional

HSMN NewsFeed - 13 Feb 2008
DaVita Announces Chief Financial Officer
Personnel

HSMN NewsFeed - 6 Feb 2008
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Jan 2008
SYMLIN Pen-Injector Devices Now Available
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2007
GSK Revises US Labeling for Avandia(R)
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 9 Nov 2007
Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 8 Nov 2007
Amicus Therapeutics and Shire plc Enter Into $440 Million ex-US Licensing Agreement to Develop and Commercialize Amigal(TM), Plicera(TM) and At2220
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Nov 2007
Shire Expands its Human Genetic Therapies Pipeline Through In-Licensing Agreement With Amicus Therapeutics
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Nov 2007
Fresenius Medical Care Announces: Continued Positive Data from CARE-2 Database
Biopharmaceuticals

HSMN NewsFeed - 5 Nov 2007
Post-Stroke Patients Treated with Lipitor Demonstrated Significant Improvement or Stabilization of Kidney Function
Biopharmaceuticals Cardiology

HSMN NewsFeed - 25 Oct 2007
Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia
Biopharmaceuticals

HSMN NewsFeed - 25 Oct 2007
Meda Acquires Recip
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Oct 2007
MedaSorb Completes Key Step to Begin Clinical Study in Europe for CytoSorb(TM) in the Treatment of Sepsis
Devices

HSMN NewsFeed - 10 Oct 2007
Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia
Biopharmaceuticals

HSMN NewsFeed - 1 Oct 2007
NxStage Medical Completes Acquisition of Medisystems
Devices Mergers & Acquisitions

HSMN NewsFeed - 1 Oct 2007
FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
Devices Drug Delivery Endocrinology FDA

HSMN NewsFeed - 25 Sep 2007
Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
Devices Interventional

HSMN NewsFeed - 24 Sep 2007
FlowMedica Inc. Launches the Benephit(R) XT Infusion System
Devices Drug Delivery

HSMN NewsFeed - 20 Sep 2007
Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
Regenerative Medicine Urology

HSMN NewsFeed - 11 Sep 2007
GlaxoSmithKline Responds to JAMA Articles
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Sep 2007
Aspreva Provides Update On Lupus Nephritis Development Program
Biopharmaceuticals

HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
Biopharmaceuticals Oncology Litigation Licensing

HSMN NewsFeed - 4 Sep 2007
Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
Biopharmaceuticals

HSMN NewsFeed - 29 Aug 2007
NxStage Medical Provides Update on Medisystems Acquisition
Devices Mergers & Acquisitions Personnel

HSMN NewsFeed - 27 Aug 2007
SPP100 (Rasilez) Receives EU Approval
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Aug 2007
Internationally Renowned Artificial Organs Expert Joins HepaLife(TM)
Devices Personnel

HSMN NewsFeed - 30 Jul 2007
MedaSorb to Pursue 6 Billion Dollar Sepsis Market in Europe
Devices Regulatory

HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Jun 2007
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
Biopharmaceuticals

HSMN NewsFeed - 23 Jun 2007
SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 Jun 2007
Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B(R) Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 11 Jun 2007
FDA Accepts and Grants Priority Review of ERBITUX(R) (Cetuximab) sBLA for Overall Survival in Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 6 Jun 2007
Aspreva announces Fast-Track designation granted by the FDA for CellCept in lupus nephritis
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Jun 2007
Statement of Moncef Slaoui, PhD, Chairman Research & Development GlaxoSmithKline
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 May 2007
DexCom(TM) Receives FDA Approval for Its 7-Day STS(R) Continuous Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 30 Apr 2007
Tengion Names Dr. Sharon Presnell as VP for Regenerative Medicine & Biology
Regenerative Medicine Personnel

HSMN NewsFeed - 16 Apr 2007
Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Apr 2007
XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Mar 2007
EVEREST Data on Short- and Long-Term Use of Otsuka's Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACC's Late Breaking Clinical Trials
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Mar 2007
CardioMEMS, Inc. Announces First Patient Implant of Wireless Pressure Sensor for Hypertension Monitoring
Devices Cardiology Monitoring

HSMN NewsFeed - 19 Mar 2007
Medtronic Launches New Guardian(R) REAL-Time System with Miniature Transmitter and CareLink(TM) Personal Software
Devices Endocrinology

HSMN NewsFeed - 2 Mar 2007
FDA Approves Astellas' Vaprisol(R) for the Treatment of Hypervolemic Hyponatremia
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Feb 2007
Human Genome Sciences and GlaxoSmithKline Announce Initiation of Phase 3 Clinical Trial of LymphoStat-B(R) in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 7 Feb 2007
DaVita and NxStage(R) Medical Announce Agreement for Home Hemodialysis
Devices

HSMN NewsFeed - 7 Feb 2007
NxStage(R) Medical and DaVita Announce Agreement for Home Hemodialysis Using the NxStage System One(TM)
Devices

HSMN NewsFeed - 5 Feb 2007
ImClone Systems Incorporated and Bristol-Myers Squibb Announce Application In Japan for Use of ERBITUX in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 1 Feb 2007
Fresenius Medical Care and Amgen Enter New Commercial Collaboration in Europe
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2007
Fresenius Medical Care and Amgen Establish a Joint Research Program in Europe
Biopharmaceuticals

HSMN NewsFeed - 11 Jan 2007
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 10 Jan 2007
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jan 2007
Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ
Regenerative Medicine Urology

HSMN NewsFeed - 27 Dec 2006
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Announce Exclusive Licensing Agreement for Diabetes Compound Saxagliptin in Japan
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 18 Dec 2006
Orphan Therapeutics Announces Rolling NDA Submission for LUCASSIN(TM) (terlipressin) to Treat Type 1 Hepatorenal Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Dec 2006
Radiant Medical Trial Shows Promising Results in Preventing Kidney Damage
Devices

HSMN NewsFeed - 6 Dec 2006
Premier Expands B. Braun Contract to Include Disposable Renal Division Products
Devices Group Purchasing

HSMN NewsFeed - 4 Dec 2006
Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More Effective Than Metformin or a Sulfonylurea in Long-Term Blood Sugar Control in Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 27 Nov 2006
NxStage Medical, Inc. Appoints Robert S. Brown as Chief Financial Officer
Devices Personnel

HSMN NewsFeed - 15 Nov 2006
Intensive Lipitor Therapy Reduced Heart Attack and Stroke By One-Third In Patients With Chronic Kidney Disease, New Analysis Shows
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 Nov 2006
Fresenius Medical Care Completes the Acquisition of the Phosphate Binder Business From Nabi Biopharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 14 Nov 2006
Human Genome Sciences Announces Positive 76-Week Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2006
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Oct 2006
Human Genome Sciences Announces Positive Special Protocol Assessment From FDA for Phase 3 Clinical Trials of LymphoStat-B(TM) In Systemic Lupus Erythematosus
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Oct 2006
Radiant Medical Initiates Clinical Trial of Therapeutic Cooling for Kidney Protection
Devices

HSMN NewsFeed - 19 Oct 2006
Fresenius Medical Care Announces New Sourcing and Supply Agreement with Amgen
Biopharmaceuticals

HSMN NewsFeed - 12 Oct 2006
Fresenius Medical Care to Acquire Phosphate Binder Business from Nabi Biopharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Oct 2006
Spectrum Pharmaceuticals Announces Positive Phase 2 Data with Ozarelix in Patients with Benign Prostatic Hypertrophy
Biopharmaceuticals Urology

HSMN NewsFeed - 27 Sep 2006
Medtronic Achieves Key Milestones in Rapidly Growing Peripheral Vascular Business
Devices Interventional

HSMN NewsFeed - 25 Sep 2006
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Sep 2006
Type 2 Diabetes Patients on Technosphere Insulin Exhibited No Adverse Effect on Pulmonary Function with Significant HbA1c Reductions, and Showed Significant Weight Reduction Compared to Injected Insulin Analog
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 7 Sep 2006
SYMLIN Improved Diabetes Control in Patients With Type 2 Diabetes on Established Regimens of Basal Insulin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 20 Jul 2006
Fresenius Medical Care Receives Regulatory Approval for New Phosphate Binding Agent in Germany
Devices Regulatory

HSMN NewsFeed - 17 Jul 2006
Medtronic Receives FDA Approval for Guardian(R) REAL-Time Continuous Glucose Monitoring System
Devices Endocrinology FDA

HSMN NewsFeed - 16 Jul 2006
Amgen Announces EVOLVE Trial(TM) To Investigate Impact of Sensipar(R)/Mimpara(R) (cinacalcet HCl) on Mortality and Cardiovascular Morbidity in Secondary Hyperparathyroidism Patients With Chronic Kidney Disease Receiving Dialysis
Biopharmaceuticals

HSMN NewsFeed - 27 Jun 2006
Abbott Enters Agreement With Cincinnati Children's Hospital to Develop Test to Detect Acute Kidney Failure
Diagnostics

HSMN NewsFeed - 22 Jun 2006
La Jolla Pharmaceutical Company Files Marketing Authorization Application for European Regulatory Approval of Riquent
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Jun 2006
Human Genome Sciences Announces Full Presentation of Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 17 May 2006
New Phase III Data on Renin Inhibitor SPP100 (Rasilez) in Treatment of Hypertension Demonstrates Potential of This First-in-Class Drug
Biopharmaceuticals

HSMN NewsFeed - 16 May 2006
NxStage Announces Executive Transition
Devices Personnel

HSMN NewsFeed - 16 May 2006
Studies Shows Device-Guided Paced Breathing Lowers Blood Pressure & Peripheral Resistance
Devices

Return to NewsFeed

Additional items found! 181

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 181 additional stories matching:
kidney failure
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!